These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

786 related items for PubMed ID: 18382882

  • 1. Introducing human papillomavirus vaccines - questions remain.
    Paavonen J, Lehtinen M.
    Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
    [Abstract] [Full Text] [Related]

  • 2. Quadrivalent human papillomavirus vaccine.
    Barr E, Tamms G.
    Clin Infect Dis; 2007 Sep 01; 45(5):609-7. PubMed ID: 17682997
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun 01; 16(89):91-4. PubMed ID: 17582921
    [Abstract] [Full Text] [Related]

  • 4. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S, Alain S, Denis F.
    Gynecol Obstet Fertil; 2006 Jun 01; 34(7-8):647-55. PubMed ID: 16807045
    [Abstract] [Full Text] [Related]

  • 5. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J.
    Gynecol Obstet Fertil; 2006 Mar 01; 34(3):189-201. PubMed ID: 16529969
    [Abstract] [Full Text] [Related]

  • 6. Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.
    Schwarz TF.
    Adv Ther; 2009 Nov 01; 26(11):983-98. PubMed ID: 20024678
    [Abstract] [Full Text] [Related]

  • 7. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep 01; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

  • 8. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M, Dillner J.
    J Clin Virol; 2007 Mar 01; 38(3):189-97. PubMed ID: 17258503
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines.
    Hampl M.
    Minerva Med; 2007 Apr 01; 98(2):121-30. PubMed ID: 17519854
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlating immunity with protection for HPV infection.
    Frazer I.
    Int J Infect Dis; 2007 Nov 01; 11 Suppl 2():S10-6. PubMed ID: 18162240
    [Abstract] [Full Text] [Related]

  • 16. Preventive and therapeutic HPV vaccines.
    Monie A, Hung CF, Wu TC.
    Curr Opin Investig Drugs; 2007 Dec 01; 8(12):1038-50. PubMed ID: 18058574
    [Abstract] [Full Text] [Related]

  • 17. [HPV vaccination: principles, results and future perspectives].
    Rouzier R, Uzan C, Collinet P.
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb 01; 36(1):13-8. PubMed ID: 17293248
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM, Reynolds SM, Jacobson RM.
    Postgrad Med; 2010 Mar 01; 122(2):121-9. PubMed ID: 20203463
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.